Fuente: Prohibición Partners Lugar: General Market Overview



Switzerland began its first adult-use pilot sales in 2023 and now operates seven active projects, allowing enrolled participants to legally purchase cannabis under controlled conditions. Early findings indicate efficient operations, no notable public-order issues, and positive health-system integration signals.



Aggregate 2025 pilot sales are estimated at €XXX (refer to Prohibition Partners’ market sizing). In parallel, Switzerland advanced toward full commercial legalisation in 2025, positioning the country to potentially launch Europe’s first nationwide adult-use market in 2026.



Legislative Track to Full Legalisation (2025 → 2026)



Process & Timing: An explanatory report precedes a summer consultation; if passed, implementation is expected in 2026—creating Europe’s first fully commercial adult-use regime.



February 2025: The National Council’s Social Security & Health Committee backed a preliminary draft bill to legalise adult-use cannabis, permitting adults to grow, buy, possess, and consume.



Model: State-monopoly retail via a limited number of licensed outlets; THC-based taxation differentiated by form of consumption; revenues earmarked for redistribution via health insurance.



Home Grow: Up to three female plants per adult. Possession thresholds to be finalised.



Cantonal Role: Cantons retain significant oversight on implementation.



Pilot Projects Framework (since 2021)




Legal basis enables scientific pilot trials to assess impacts of regulated sales on consumer behaviour, public health, youth protection, illicit markets, and public safety.



Seven trials active; up to 5,000 participants per trial; ~10,000 active buyers across projects.



Purchase caps: 10 g THC/month (equivalent to 50–100 g flower, depending on potency).



All trials run by public institutions (universities, research institutes, municipalities, foundations).




Pilot Projects: Profiles, Products, Interim Results



Weed Care (Basel-Stadt)




Max participants: 378 | Active: 299 (Mar 2025)



Sales start: 30 Jan 2023 | End: Jan 2027



Organisers: Health Dept. Basel-Stadt; UPK Basel; PD-AG; University of Basel



Focus: Compare pharmacy-based regulated sales vs illegal sourcing; extension assesses outcome changes when legal access ceases.




Products & Prices (producer: Pure Holding AG)



Strain / FormatTHCCBDPrice (CHF/g)Girl Scout Cookies (Flower)20%<1%11.00Amnesia Passion (Flower)12%<1%10.00Green Mango (Flower)8%8%9.00Lemon Diesel (Flower)6%12%8.00Diesel Pollen (Hash)20%5%12.00Lemon Resin (Hash)15%5%11.00Vape High THC (Vape)20%5%30.00Vape Balanced (Vape)10%10%25.00Oil 10 ml (Oil)18%<1%65.00Spray 10 ml (Spray)5%5%55.00



Interim Results (Mar 2025)




87 kg sold; ~CHF 900k shifted from illicit market.



⅓ of purchases <13% THC; no increase in purchase volume or consumption.



89% join to support regulation; 84% value higher product quality; 79% cite safer access.




Züri Can (Zürich)




Max: 3,000 | Active: 2,232 (Apr 2025)



Sales start: 22 Aug 2023 | End: Oct 2026



Organisers: City & University of Zürich



Focus: Health and consumption effects; multi-channel distribution (10 pharmacies, 10 cannabis social clubs, 1 Drug Info Centre).




Products & Prices (Pure Production AG; SwissExtract)



ProductFormatTHCCBDPrice (CHF/g)ProducerSour PollenHash20%5%9.80Pure ProductionJura GoldHash20%5%9.80SwissExtractGrand MaraisHash15%10%8.80SwissExtractWedding CakeFlower20%0%9.80SwissExtractBlue DreamFlower18%0%9.60Pure ProductionSuper Lemon HazeFlower15%0%9.30Pure ProductionCleopatra’s MilkFlower14.5%0%9.30SwissExtractCherry Valley CakeFlower14%0%9.20SwissExtractCairo DessertFlower12%0%9.00SwissExtractApricot MimosaFlower9%8%7.90SwissExtract



Interim Results (Apr 2025)




~150 dropouts (survey lapses/cessation of use).



Demographics: 80% male; 18.7% female; 1.3% non-binary; avg age ~35 (largest 28–32 y/o cohort).



Use frequency: 55.8% ≥4×/week; 28.3% 2–3×/week.



High satisfaction with product quality and prevention/counselling materials.




Grashaus Projects (Basel-Landschaft)




Max: 3,950 | Active: >1,000 (Aug 2024)



Sales start: 7 Dec 2023 | End: Oct 2028



Organisers: ISGF; Sanity Group Switzerland AG



Focus: Specialty-store sales with trained staff; measure harm reduction and shift from illicit market.




Products & Prices (SwissExtract; 5-g packs)



NameFormatTHCCBDCherry Valley CakeFlower17%<1%Wedding CakeFlower20%<1%JBT KushFlower20%<1%Cleopatra’s MilkFlower18%<1%Mother’s ChoiceFlower17%<1%AlpenglowFlower15%<1%FrieslandFlower14%<1%Cairo DessertFlower12%<1%Apricot MimosaFlower9%8%CiskeiFlower5%8%



Interim Results (12-month)




~⅔ of participants purchase almost exclusively in licensed stores (reduced illicit reliance).



Shift toward lower-risk forms (edibles, oral solutions, vapes).



Low dropout; high satisfaction and research motivation.




Cann-L (Lausanne)




Max: 1,600 | Active: 1,396 (Mar 2025)



Sales start: 11 Dec 2023 | End: Summer 2027



Organisers: City of Lausanne; Addiction Suisse



Focus: Non-profit retail model; strong advice & health objectives.




Products & Prices (secret 10,000 m² site; flowers)



NameTHCPrice (CHF/g)Alpha<5%9–12Beta5–10%9–12Gamma10–15%9–12Delta15%9–12



Year-1 Results (Dec 2024)




>10 kg sold in Nov 2024 (~15% of Lausanne’s monthly consumption; ~CHF 1m equivalent).



Participants: 18–80 y/o (avg 37); 77% male; 67% employed.



Stable consumption; >25% of flower sales <10% THC; 38 participants sought medical advice.




La Cannabinothèque (Vernier, Geneva)




Max: 1,200 | Active: 1,100 (Dec 2024)



Sales start: 11 Dec 2023 | End: Jun 2027



Organisers: University of Geneva (IRS); HUG; Association ChanGE; Municipality of Vernier; FEGPAC



Focus: Effects of regulated access on knowledge, risk reduction, and neighbourhood impact.




Products & Prices




Range of flowers, one hash, one oil; CHF 9–12/g (3-g packs); varied THC/CBD.



Cultivated at a 10,000 m² greenhouse (French-speaking region).




Year-1 Findings (Dec 2024)




Participants 18–80 y/o; ~80% male.



⅓ under 30; ½ between 30–50; 20% over 50.



Unexpectedly high demand for low-THC products (min 4% offered).




SCRIPT (Bern, Biel & Lucerne)




Max: 1,091 | Active: 1,091 (Mar 2025)



Sales start: Apr 2024 (Bern); Jun 2024 (Biel & Lucerne) | End: Apr 2026



Organisers: University of Bern (BIHAM, CTU, ISPM, UPD); University of Lucerne (Zentrum für Hausarztmedizin und Community Care)



Funders: SNSF; Tobacco Control Fund; cities



Focus: Effects of pharmacy-based sales on consumption & health; tobacco co-use.




Products (Pure Production AG)




Four flowers; two hash; two tincture sprays; two e-liquids (prices undisclosed; proceeds cost-cover the experiment).




Early Snapshot




Bern registrations: ~80% men; 18% women; 2% non-binary.




Cannabis Research Zürich (Canton of Zürich)




Max: 7,500 (A 2,500 / B 2,500 / C 2,500 no-access control) | Active: 3,900 (Dec 2024)



Sales start: 2 May 2024 | End: Dec 2028



Organisers: ETH Zürich (KOF); University of Zürich (Economics) | Funder: Swiss Cannabis Research Association



Focus: RCT on social & economic impacts; self-regulation programme; sales via 3 specialty stores + 8 pharmacies.




Products & Prices (SwissExtract; Alpina Pharma; Charlie’s Lab)



ProductFormatTHCCBDPriceWedding CakeFlower20%<1%CHF 12/gAmnesia HazeFlower20%<1%CHF 12/gRoyal FeastFlower15%<1%CHF 11/gBubba KushFlower15%<1%CHF 11/gApricot MimosaFlower9%8%CHF 8/gCiskieFlower5%7.5%CHF 7/gGrand MariasHash15%10%CHF 10/gJura GoldHash20%<5%CHF 12/gFumo D’OroVape20%<2%CHF 40/mlFumo D’Oro BalancedVape20%20%CHF 41/ml



Results: Limited public data to date; interim analyses pending.



Pipeline Projects (Ticino & Others)




Multiple applications reportedly under review by the FOPH; two confirmed submissions in Ticino (incl. “Cannabis in Ticino” with University of St. Gallen & Areté Solutions).



March 2025: Ticino Grand Council declined to take supportive action; however, cantonal opposition does not automatically block FOPH approval. Federal decisions are pending.








Stay Informed with the Insights Hub



Switzerland’s adult-use framework continues to evolve, creating both challenges and opportunities for patients, policymakers, and businesses. To access deeper analysis, data, and market forecasts, join our Insights Hub — your gateway to industry intelligence across global cannabis markets.




Sign Up Now For Free








Market Outlook



Switzerland’s pilot programme is generating robust, multi-site evidence on regulated access, with early signals of illicit-market displacement, demand for lower-THC options, and no measurable escalation in consumption among participants.



With pre-legislative approval secured and consultations scheduled, Switzerland is on a credible path to launch a national, state-monopoly retail model in 2026, likely becoming Europe’s first fully commercial adult-use market. Results from the pilots will directly inform product standards, retail design, taxation, and public-health safeguards in the final law.





















Recommended products









£1,429.00




Buy now



View cart











£1,819.00




Buy now



View cart











£2,839.00




Buy now



View cart











£1,849.00




Buy now



View cart

































The post Switzerland: Adult-Use Cannabis Market Overview 2025 appeared first on Prohibition Partners.